Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand

Rhea-AI Summary

Co-Diagnostics, Inc. will be hosting a booth at Asia Health/Medlab Asia 2023 in Bangkok, Thailand. The conference is a valuable platform for the healthcare industry, expecting over 7,500 attendees. The Company will showcase its Co-Primer™ PCR technology, infectious disease products, and upcoming Co-Dx PCR Home testing platform.

SALT LAKE CITY, Aug. 16, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at Asia Health/Medlab Asia 2023 from August 16-18 at the IMPACT Exhibition Center in Bangkok, Thailand.

The Asia Health/Medlab Asia conference is intended to bring together healthcare and laboratory communities to network and do business in what the conference website describes as the region's most valuable platform for the healthcare industry, with over 7,500 visitors, delegates, distributors, and senior lab and healthcare executives expected to be in attendance.

The Company's booth will showcase Co-Diagnostics' state-of-the-art Co-Primer™ PCR technology and infectious disease products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform which is subject to FDA review and is not available for sale.

Additional details, including registration information, can be found here.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medlab-asia-conference-in-bangkok-thailand-301902656.html

SOURCE Co-Diagnostics

FAQ

What is Co-Diagnostics, Inc.?

Co-Diagnostics, Inc. is a molecular diagnostics company.

Where will Asia Health/Medlab Asia 2023 take place?

The conference will be held at the IMPACT Exhibition Center in Bangkok, Thailand.

What will Co-Diagnostics showcase at the conference?

Co-Diagnostics will showcase its Co-Primer™ PCR technology, infectious disease products, and upcoming Co-Dx PCR Home testing platform.

Is the Co-Dx PCR Home testing platform available for sale?

No, the platform is subject to FDA review and is not available for sale.

How many attendees are expected at the conference?

Over 7,500 visitors, delegates, distributors, and senior lab and healthcare executives are expected to be in attendance.